share_log

Neumora Therapeutics Has Initiated A Phase 1 Single Ascending Dose / Multiple Ascending Dose Study Of NMRA-266 In Healthy Adult Participants For Schizophrenia And Other Neuropsychiatric Disorders

Benzinga ·  11/27/2023 20:13

Neumora Therapeutics Has Initiated A Phase 1 Single Ascending Dose / Multiple Ascending Dose Study Of NMRA-266 In Healthy Adult Participants For Schizophrenia And Other Neuropsychiatric Disorders

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment